advocacy

First Opinion By Winnie Byanyima and Chip Lyons

A turning point for children: creating an AIDS-free generation

First Opinion By Michael S. Sinha and Stephen Latham

Patient advocacy organizations and FDA drug approval: lessons from Aduhelm

First Opinion By Leslie Boden, Will Raderman, and Patricia Fabian

Circumventing Covid-19 with better ventilation and air quality

Politics By Rachel Cohrs

Pharma CEOs, lobbyists showered Democrat with cash after his attempt to torpedo Pelosi’s drug pricing bill

First Opinion By Margaret Goldberg

Patient advocacy groups and innovators must partner to advance new treatments

Politics By Nicholas Florko

Is the Alzheimer’s Association really pushing Biogen to lower its new drug’s price — or is it lip service?

First Opinion By Kollet Koulianos and Keri Norris

Copay assistance should count as part of patients’ cost sharing for medications

D.C. Diagnosis By Nicholas Florko

Operation Warp Speed — now, the ‘CAG’— is here to stay

First Opinion By David Introcaso and Walt Vernon

Public reporting: the first step in addressing the health care industry’s bloated carbon footprint

First Opinion By Lipi Roy, Reshma Gupta, and Bhavna Lall

India’s doctors — at home and abroad — face Covid’s unrelenting toll

Politics By Nicholas Florko

Bipartisan pair of senators calls on Congress to examine expensive new Alzheimer’s drug 

D.C. Diagnosis By Rachel Cohrs

The lonely quest to create a commission to investigate Covid-19

Politics By Rachel Cohrs

Biogen isn’t the only drug company that will profit from the new Alzheimer’s drug Aduhelm

Politics By Nicholas Florko

BIO’s chief on the FDA commissioner rumors, drug pricing, and IP rights 

First Opinion By Dan Troy

3D bioprinting can help end organ transplant waitlists — if the FDA stops delaying

Politics By Rachel Cohrs

Buying the data: Health care lobbyists fund their own policy analyses, clouding Washington debates

First Opinion By Rohit Malpani

If vaccine apartheid exists, vaccine billionaires shouldn’t

First Opinion By Linda Richter and Lindsey Vuolo

Lessons about marijuana edibles from youth vaping

Prescription Politics By Lev Facher

More than two-thirds of Congress cashed a pharma campaign check in 2020, new STAT analysis shows

First Opinion By Gideon Meyerowitz-Katz and James Heathers

Scientific publishing’s new weapon for the next crisis: the rapid correction

First Opinion By Adeeba Kamarulzaman

With Covid-19, as with HIV, science and partnerships with communities lead the way

First Opinion By William Cooke and Gregg Gonsalves

Closing an Indiana county’s syringe services program would be a public health disaster

First Opinion By George Vradenburg and Ellen V. Sigal

Created correctly, the Advanced Research Projects Agency for Health will accelerate medical innovation

First Opinion By Gagan K. Thapa and Duncan Maru

In ‘vaccine apartheid,’ Nepal is ground zero. It needs U.S. help

First Opinion By David Blumenthal

Restore a better balance to public-private funding of biomedical research